PC-7 p<0.000010 High/Low PC-7 Value ProbeId Name Aliases LocusLink Description Function Protein_Families high 18.6251549359 202404_s_at COL1A2 COL1A2;OI4 1278 collagen, type I, alpha 2 collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);phosphate transport (GO:0006817);skeletal development (GO:0001501);structural constituent of bone (GO:0008147) Fibrillar collagen, C-terminal (IPR000885);Proline-rich region (IPR000694) high 17.8883098664 201744_s_at LUM LDC;LUM;SLRR2D 4060 lumican collagen binding (GO:0005518);collagen fibril organization (GO:0030199);extracellular matrix glycoprotein (GO:0005207);extracellular matrix structural constituent (GO:0005201);proteoglycan (GO:0005203);visual perception (GO:0007601) Cysteine-rich flanking region, N-terminal (IPR000372) high 15.4804250396 204083_s_at TPM2 AMCD1;DA1;TMSB;TPM2 7169 tropomyosin 2 (beta) actin binding (GO:0003779);muscle development (GO:0007517);structural constituent of muscle (GO:0008307) Tropomyosin (IPR000533) high 15.3045581851 201162_at IGFBP7 FSTL2;IGFBP-7;IGFBP7;MAC25;PSF 3490 insulin-like growth factor binding protein 7 insulin-like growth factor binding (GO:0005520);negative regulation of cell proliferation (GO:0008285);regulation of cell growth (GO:0001558) Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);Insulin-like growth factor-binding protein, IGFBP (IPR000867);Proteinase inhibitor I1, Kazal (IPR002350) high 14.5352764823 212097_at CAV1 CAV;CAV1;VIP21 857 caveolin 1, caveolae protein, 22kDa structural molecule activity (GO:0005198);tumor suppressor (GO:0008181) Caveolin (IPR001612) high 14.0783440126 215076_s_at COL3A1 COL3A1 1281 collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) circulation (GO:0008015);collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);histogenesis and organogenesis (GO:0007397);organogenesis (GO:0009887);phosphate transport (GO:0006817) Fibrillar collagen, C-terminal (IPR000885);Fibrinogen, beta/gamma chain, C-terminal globular (IPR002181);Proline-rich region (IPR000694);Surface protein from Gram-positive cocci, anchor region (IPR001899);von Willebrand factor, type C (IPR001007) high 13.8386214656 212192_at KCTD12 C13orf2;KCTD12;KIAA1778 115207 potassium channel tetramerisation domain containing 12 potassium ion transport (GO:0006813);protein binding (GO:0005515);voltage-gated potassium channel activity (GO:0005249) K+ channel tetramerisation (IPR003131) high 13.8336681397 202310_s_at COL1A1 COL1A1;OI4 1277 collagen, type I, alpha 1 collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);perception of sound (GO:0007605);phosphate transport (GO:0006817);skeletal development (GO:0001501);structural constituent of bone (GO:0008147) Fibrillar collagen, C-terminal (IPR000885);Fibrinogen, beta/gamma chain, C-terminal globular (IPR002181);Proline-rich region (IPR000694);von Willebrand factor, type C (IPR001007) high 13.7128749727 202291_s_at MGP MGLAP;MGP;NTI 4256 matrix Gla protein calcium ion binding (GO:0005509);extracellular matrix structural constituent (GO:0005201);oncogenesis (GO:0007048);perception of sound (GO:0007605);structural constituent of bone (GO:0008147) Bone matrix, Gla region (IPR002384);Vitamin K-dependent carboxylation/gamma-carboxyglutamic region (IPR000294) high 13.568255456 211161_s_at COL3A1 COL3A1 1281 collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) circulation (GO:0008015);collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);histogenesis and organogenesis (GO:0007397);organogenesis (GO:0009887);phosphate transport (GO:0006817) Fibrillar collagen, C-terminal (IPR000885);Fibrinogen, beta/gamma chain, C-terminal globular (IPR002181);Proline-rich region (IPR000694);Surface protein from Gram-positive cocci, anchor region (IPR001899);von Willebrand factor, type C (IPR001007) high 13.2486771675 201616_s_at CALD1 CALD1;CDM;H-CAD;L-CAD;MGC21352;NAG22 800 caldesmon 1 actin binding (GO:0003779);calmodulin binding (GO:0005516);muscle contraction (GO:0006936);muscle development (GO:0007517);myosin binding (GO:0017022);tropomyosin binding (GO:0005523) Bipartite nuclear localization signal (IPR001472);Caldesmon (IPR006017);Caldesmon and lymphocyte specific protein (IPR006018) high 13.1855955521 201058_s_at MYL9 LC20;MGC3505;MLC2;MRLC1;MYL9;MYRL2 10398 myosin, light polypeptide 9, regulatory calcium ion binding (GO:0005509);structural constituent of muscle (GO:0008307) Calcium-binding EF-hand (IPR002048) high 13.1245055089 211719_x_at FN1 CIG;FINC;FN1;LETS;MSF 2335 fibronectin 1 acute-phase response (GO:0006953);cell adhesion (GO:0007155);cell migration (GO:0016477);collagen binding (GO:0005518);extracellular matrix structural constituent (GO:0005201);heparin binding (GO:0008201);response to wounding (GO:0009611) Aldehyde dehydrogenase (IPR002086);Bipartite nuclear localization signal (IPR001472);EGF-like domain (IPR006209);Fibronectin, type I (IPR000083);Fibronectin, type III (IPR003961);Fibronectin, type III subdomain (IPR003962);Fibronectin, type III-like fold (IPR008957);Type II fibronectin collagen-binding domain (IPR000562) high 12.7133192665 201939_at PLK2 PLK2;SNK 10769 polo-like kinase 2 (Drosophila) ATP binding (GO:0005524);positive regulation of I-kappaB kinase/NF-kappaB cascade (GO:0043123);protein amino acid phosphorylation (GO:0006468);protein serine/threonine kinase activity (GO:0004674);signal transducer activity (GO:0004871);transferase activity (GO:0016740) POLO box duplicated region (IPR000959);Protein kinase (IPR000719);Serine/threonine protein kinase (IPR002290);Tyrosine protein kinase (IPR001245) high 12.5858996563 212077_at CALD1 CALD1;CDM;H-CAD;L-CAD;MGC21352;NAG22 800 caldesmon 1 actin binding (GO:0003779);calmodulin binding (GO:0005516);muscle contraction (GO:0006936);muscle development (GO:0007517);myosin binding (GO:0017022);tropomyosin binding (GO:0005523) Bipartite nuclear localization signal (IPR001472);Caldesmon (IPR006017);Caldesmon and lymphocyte specific protein (IPR006018) high 12.5402497092 209101_at CTGF CCN2;CTGF;IGFBP8;NOV2 1490 connective tissue growth factor DNA metabolism (GO:0006259);cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);cell growth and/or maintenance (GO:0008151);cell motility (GO:0006928);heparin binding (GO:0008201);insulin-like growth factor binding (GO:0005520);protein binding (GO:0005515);regulation of cell growth (GO:0001558);response to wounding (GO:0009611) Cystine knot domain (IPR006208);Cystine knot, C-terminal (IPR006207);Insulin-like growth factor-binding protein, IGFBP (IPR000867);von Willebrand factor, type C (IPR001007) high 12.3855645771 212013_at D2S448 D2S448;D2S448E;KIAA0230;MG50;PRG2;PXN 7837 Melanoma associated gene immune response (GO:0006955);interleukin-1 receptor antagonist activity (GO:0005152);peroxidase activity (GO:0004601) Animal haem peroxidase (IPR002007);Cysteine-rich flanking region, C-terminal (IPR000483);Cysteine-rich flanking region, N-terminal (IPR000372);Haem peroxidase (IPR010255);Immunoglobulin C-2 type (IPR003598);Immunoglobulin-like (IPR007110);von Willebrand factor, type C (IPR001007) high 12.2755663055 213764_s_at MFAP5 MAGP2;MFAP5;MP25 8076 microfibrillar associated protein 5 extracellular matrix structural constituent (GO:0005201) Microfibril-associated glycoprotein (IPR008673) high 12.2372042261 203789_s_at SEMA3C SEMA3C;SEMAE;SemE 10512 sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C cell growth and/or maintenance (GO:0008151);development (GO:0007275);drug resistance (GO:0009315);immune response (GO:0006955);response to drug (GO:0042493) Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);Semaphorin/CD100 antigen (IPR001627) high 12.2034178679 222162_s_at ADAMTS1 ADAMTS1;C3-C5;KIAA1346;METH1 9510 a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1 heparin binding (GO:0008201);hydrolase activity (GO:0016787);integrin binding (GO:0005178);integrin-mediated signaling pathway (GO:0007229);metalloendopeptidase activity (GO:0004222);metallopeptidase activity (GO:0008237);negative regulation of cell proliferation (GO:0008285);proteolysis and peptidolysis (GO:0006508);zinc ion binding (GO:0008270) ADAM, cysteine-rich (IPR006586);ADAM-TS Spacer 1 (IPR010294);Cytochrome P450 (IPR001128);Disintegrin (IPR001762);Peptidase M12B, ADAM/reprolysin (IPR001590);Peptidase M12B, propeptide (IPR002870) high 11.9930896279 200665_s_at SPARC SPARC 6678 secreted protein, acidic, cysteine-rich (osteonectin) calcium ion binding (GO:0005509);collagen binding (GO:0005518) Calcium-binding EF-hand (IPR002048);Follistatin-like, N-terminal (IPR003645);Osteonectin-like (IPR001999);Proteinase inhibitor I1, Kazal (IPR002350) high 11.7599724425 204363_at F3 CD142;TFA 2152 coagulation factor III (thromboplastin, tissue factor) blood coagulation (GO:0007596);blood coagulation factor activity (GO:0003801);hematopoietin/interferon-class (D200-domain) cytokine receptor activity (GO:0004896);immune response (GO:0006955);receptor activity (GO:0004872);transmembrane receptor activity (GO:0004888) Cytokine receptor class 2 (IPR000282);Fibronectin, type III-like fold (IPR008957);Tissue factor (IPR001187) high 11.7111073825 201215_at PLS3 PLS3;T-PLASTIN 5358 plastin 3 (T isoform) actin binding (GO:0003779);calcium ion binding (GO:0005509) Actin-binding, actinin-type (IPR001589);Calcium-binding EF-hand (IPR002048);Calponin-like actin-binding (IPR001715) high 11.6954939578 201110_s_at THBS1 THBS;THBS1;TSP;TSP1 7057 thrombospondin 1 blood coagulation (GO:0007596);calcium ion binding (GO:0005509);cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);cell motility (GO:0006928);development (GO:0007275);endopeptidase inhibitor activity (GO:0004866);heparin binding (GO:0008201);neurogenesis (GO:0007399);protein binding (GO:0005515);signal transducer activity (GO:0004871);structural molecule activity (GO:0005198) EGF-like calcium-binding (IPR001881);EGF-like domain (IPR006209);Laminin G (IPR001791);Thrombospondin, C-terminal (IPR008859);Thrombospondin, N-terminal (IPR003129);Type I EGF (IPR006210);von Willebrand factor, type C (IPR001007) high 11.6865835057 202620_s_at PLOD2 PLOD2 5352 procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2 oxidoreductase activity (GO:0016491);oxidoreductase activity\, acting on single donors with incorporation of molecular oxygen\, incorporation of two atoms of oxygen (GO:0016702);procollagen-lysine 5-dioxygenase activity (GO:0008475);protein metabolism (GO:0019538);protein modification (GO:0006464) 2OG-Fe(II) oxygenase superfamily (IPR005123);Procollagen-lysine 5-dioxygenase (IPR001006);Prolyl 4-hydroxylase, alpha subunit (IPR006620) high 11.3735841816 203065_s_at CAV1 CAV;CAV1;VIP21 857 caveolin 1, caveolae protein, 22kDa structural molecule activity (GO:0005198);tumor suppressor (GO:0008181) Caveolin (IPR001612) high 11.3642862548 gnf1h04130_x_at gnf1h04130_x_at None None None None None high 11.281283761 212464_s_at FN1 CIG;FINC;FN1;LETS;MSF 2335 fibronectin 1 acute-phase response (GO:0006953);cell adhesion (GO:0007155);cell migration (GO:0016477);collagen binding (GO:0005518);extracellular matrix structural constituent (GO:0005201);heparin binding (GO:0008201);response to wounding (GO:0009611) Aldehyde dehydrogenase (IPR002086);Bipartite nuclear localization signal (IPR001472);EGF-like domain (IPR006209);Fibronectin, type I (IPR000083);Fibronectin, type III (IPR003961);Fibronectin, type III subdomain (IPR003962);Fibronectin, type III-like fold (IPR008957);Type II fibronectin collagen-binding domain (IPR000562) high 11.1752259286 215294_s_at SMARCA1 SMARCA1;SNF2L;SNF2L1;SNF2LB;SWI2 6594 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 ATP binding (GO:0005524);ATP-dependent helicase activity (GO:0008026);DNA binding (GO:0003677);adenosinetriphosphatase (GO:0004002);chromatin remodeling (GO:0006338);helicase activity (GO:0004386);translation regulator activity (GO:0045182) Bipartite nuclear localization signal (IPR001472);DEAD/DEAH box helicase (IPR001410);Helicase, C-terminal (IPR001650);Myb DNA-binding domain (IPR001005);SNF2 related domain (IPR000330) high 11.0775833372 205547_s_at TAGLN CGI-40;SM22;SMCC;TAGLN;WS3-10 6876 transgelin muscle development (GO:0007517) Calponin-like actin-binding (IPR001715);Calponin-like actin-binding subtype (IPR003247);SM22/calponin (IPR003096);Transgelin (SM22-alpha) (IPR001061) high 10.9481819114 211980_at COL4A1 COL4A1 1282 collagen, type IV, alpha 1 DNA binding (GO:0003677);collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);phosphate transport (GO:0006817) Proline-rich region (IPR000694) high 10.9040365769 203324_s_at CAV2 CAV;CAV2;MGC12294 858 caveolin 2 tumor suppressor (GO:0008181) Caveolin (IPR001612) high 10.8991668053 210986_s_at TPM1 CMH3;TMSA;TPM1 7168 tropomyosin 1 (alpha) actin binding (GO:0003779);muscle development (GO:0007517);regulation of heart rate (GO:0008016);structural constituent of cytoskeleton (GO:0005200);structural constituent of muscle (GO:0008307) Beta-ketoacyl synthase (IPR000794);SF_assemblin (IPR008374);Tropomyosin (IPR000533) high 10.8460278444 201667_at GJA1 CX43;DFNB38;GJA1;ODD;ODDD;ODOD;SDTY3 2697 gap junction protein, alpha 1, 43kDa (connexin 43) cell-cell signaling (GO:0007267);connexon channel activity (GO:0015285);heart development (GO:0007507);ion transporter activity (GO:0015075);muscle contraction (GO:0006936);perception of sound (GO:0007605);positive regulation of I-kappaB kinase/NF-kappaB cascade (GO:0043123);signal transducer activity (GO:0004871);small molecule transport (GO:0006832);transport (GO:0006810) Connexins (IPR000500);Gap junction alpha-1 protein (Cx43) (IPR002261) high 10.8197801724 202403_s_at COL1A2 COL1A2;OI4 1278 collagen, type I, alpha 2 collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);phosphate transport (GO:0006817);skeletal development (GO:0001501);structural constituent of bone (GO:0008147) Fibrillar collagen, C-terminal (IPR000885);Proline-rich region (IPR000694) high 10.608028506 201637_s_at FXR1 FXR1 8087 fragile X mental retardation, autosomal homolog 1 DNA binding (GO:0003677);RNA binding (GO:0003723);apoptosis (GO:0006915);nucleic acid binding (GO:0003676);nucleocytoplasmic transport (GO:0006913) Agenet (IPR008395);KH (IPR004087);KH, type 1 (IPR004088);Nucleic acid-binding OB-fold (IPR008994);NusA protein with KH region, archaeal (IPR010212) high 10.5990177978 201438_at COL6A3 COL6A3 1293 collagen, type VI, alpha 3 cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);muscle development (GO:0007517);phosphate transport (GO:0006817);protein binding (GO:0005515);serine-type endopeptidase inhibitor activity (GO:0004867) Fibronectin, type III (IPR003961);Protease inhibitor I2, Kunitz metazoa (IPR002223);von Willebrand factor, type A (IPR002035) high 10.5202995679 201289_at CYR61 CCN1;CYR61;GIG1;IGFBP10 3491 cysteine-rich, angiogenic inducer, 61 cell adhesion (GO:0007155);cell proliferation (GO:0008283);chemotaxis (GO:0006935);embryogenesis and morphogenesis (GO:0007345);heparin binding (GO:0008201);insulin-like growth factor binding (GO:0005520);morphogenesis (GO:0009653);regulation of cell growth (GO:0001558) Cystine knot domain (IPR006208);Cystine knot, C-terminal (IPR006207);Insulin-like growth factor-binding protein, IGFBP (IPR000867);von Willebrand factor, type C (IPR001007) high 10.5046655107 212698_s_at SEPT10 FLJ11619;FLJ21870;SEPT10 151011 septin 10 GTP binding (GO:0005525) Bipartite nuclear localization signal (IPR001472);Cell division/GTP binding protein (IPR000038) high 10.4445903955 202948_at IL1R1 CD121A;D2S1473;IL-1R-alpha;IL1R;IL1R1;IL1RA;P80 3554 interleukin 1 receptor, type I cell surface receptor linked signal transduction (GO:0007166);immune response (GO:0006955);inflammatory response (GO:0006954);interleukin-1 receptor activity (GO:0004908);interleukin-1\, Type I\, activating receptor activity (GO:0004909);signal transducer activity (GO:0004871);transmembrane receptor activity (GO:0004888) Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);Interleukin-1 receptor IL1R (IPR004076);Interleukin-1 receptor, type I and type II (IPR004074);Interleukin-1 receptor, type I/Toll precursor (IPR004075);TIR (IPR000157) high 10.3720820905 217975_at WBP5 LOC51186;WBP5 51186 WW domain binding protein 1 DNA binding (GO:0003677) Transcription elongation factor A, SII-related (IPR010370) high 10.3479123809 201505_at LAMB1 LAMB1 3912 laminin, beta 1 cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);protein binding (GO:0005515);structural molecule activity (GO:0005198) EGF-like domain (IPR006209);Laminin, N-terminal (IPR008211);Laminin-type EGF-like domain (IPR002049);Type I EGF (IPR006210) high 10.3325367591 201324_at EMP1 CL-20;EMP1;TMP 2012 epithelial membrane protein 1 cell death (GO:0008219);cell growth (GO:0016049);cell proliferation (GO:0008283);development (GO:0007275);oncogenesis (GO:0007048) PMP-22/EMP/MP20 (IPR004032);PMP-22/EMP/MP20 and claudin (IPR004031) high 10.2269328617 212298_at NRP1 NRP;NRP1;VEGF165R 8829 neuropilin 1 axon guidance (GO:0007411);cell adhesion (GO:0007155);cell-cell signaling (GO:0007267);histogenesis and organogenesis (GO:0007397);neurogenesis (GO:0007399);organogenesis (GO:0009887);positive regulation of cell proliferation (GO:0008284);receptor activity (GO:0004872);signal transduction (GO:0007165);vascular endothelial growth factor receptor activity (GO:0005021) CUB (IPR000859);Coagulation factor 5/8 type C domain (FA58C) (IPR000421);Galactose-binding like (IPR008979);MAM (IPR000998) high 10.1225052339 201852_x_at COL3A1 COL3A1 1281 collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) circulation (GO:0008015);collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);histogenesis and organogenesis (GO:0007397);organogenesis (GO:0009887);phosphate transport (GO:0006817) Fibrillar collagen, C-terminal (IPR000885);Fibrinogen, beta/gamma chain, C-terminal globular (IPR002181);Proline-rich region (IPR000694);Surface protein from Gram-positive cocci, anchor region (IPR001899);von Willebrand factor, type C (IPR001007) high 10.0983427573 201617_x_at CALD1 CALD1;CDM;H-CAD;L-CAD;MGC21352;NAG22 800 caldesmon 1 actin binding (GO:0003779);calmodulin binding (GO:0005516);muscle contraction (GO:0006936);muscle development (GO:0007517);myosin binding (GO:0017022);tropomyosin binding (GO:0005523) Bipartite nuclear localization signal (IPR001472);Caldesmon (IPR006017);Caldesmon and lymphocyte specific protein (IPR006018) high 10.097030863 201109_s_at THBS1 THBS;THBS1;TSP;TSP1 7057 thrombospondin 1 blood coagulation (GO:0007596);calcium ion binding (GO:0005509);cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);cell motility (GO:0006928);development (GO:0007275);endopeptidase inhibitor activity (GO:0004866);heparin binding (GO:0008201);neurogenesis (GO:0007399);protein binding (GO:0005515);signal transducer activity (GO:0004871);structural molecule activity (GO:0005198) EGF-like calcium-binding (IPR001881);EGF-like domain (IPR006209);Laminin G (IPR001791);Thrombospondin, C-terminal (IPR008859);Thrombospondin, N-terminal (IPR003129);Type I EGF (IPR006210);von Willebrand factor, type C (IPR001007) high 10.0495228838 210495_x_at FN1 CIG;FINC;FN1;LETS;MSF 2335 fibronectin 1 acute-phase response (GO:0006953);cell adhesion (GO:0007155);cell migration (GO:0016477);collagen binding (GO:0005518);extracellular matrix structural constituent (GO:0005201);heparin binding (GO:0008201);response to wounding (GO:0009611) Aldehyde dehydrogenase (IPR002086);Bipartite nuclear localization signal (IPR001472);EGF-like domain (IPR006209);Fibronectin, type I (IPR000083);Fibronectin, type III (IPR003961);Fibronectin, type III subdomain (IPR003962);Fibronectin, type III-like fold (IPR008957);Type II fibronectin collagen-binding domain (IPR000562) high 10.0276655307 212667_at SPARC SPARC 6678 secreted protein, acidic, cysteine-rich (osteonectin) calcium ion binding (GO:0005509);collagen binding (GO:0005518) Calcium-binding EF-hand (IPR002048);Follistatin-like, N-terminal (IPR003645);Osteonectin-like (IPR001999);Proteinase inhibitor I1, Kazal (IPR002350) high 10.0213287943 201163_s_at IGFBP7 FSTL2;IGFBP-7;IGFBP7;MAC25;PSF 3490 insulin-like growth factor binding protein 7 insulin-like growth factor binding (GO:0005520);negative regulation of cell proliferation (GO:0008285);regulation of cell growth (GO:0001558) Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);Insulin-like growth factor-binding protein, IGFBP (IPR000867);Proteinase inhibitor I1, Kazal (IPR002350) high 9.98938266499 212195_at IL6ST CD130;CDw130;GP130;GP130-RAPS;IL6R-beta;IL6ST 3572 interleukin 6 signal transducer (gp130, oncostatin M receptor) cell surface receptor linked signal transduction (GO:0007166);gp130 (GO:0004898);immune response (GO:0006955);interleukin-6 receptor activity (GO:0004915);oncostatin-M receptor activity (GO:0004924);receptor activity (GO:0004872);signal transduction (GO:0007165) Cytokine receptor, common beta/gamma chain (IPR002996);Fibronectin, type III (IPR003961);Fibronectin, type III-like fold (IPR008957);Long hematopoietin receptor, gp130 family 2 (IPR003529) high 9.98016937578 211651_s_at LAMB1 LAMB1 3912 laminin, beta 1 cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);protein binding (GO:0005515);structural molecule activity (GO:0005198) EGF-like domain (IPR006209);Laminin, N-terminal (IPR008211);Laminin-type EGF-like domain (IPR002049);Type I EGF (IPR006210) high 9.93716508594 202133_at TAZ DKFZP586I1419;TAZ 25937 transcriptional co-activator with PDZ-binding motif (TAZ) transcription coactivator activity (GO:0003713) WW/Rsp5/WWP domain (IPR001202) high 9.9340971586 211896_s_at DCN DCN;DSPG2;PG40;PGII;PGS2;SLRR1B 1634 decorin chondroitin sulfate/dermatan sulfate proteoglycan (GO:0005205);histogenesis and organogenesis (GO:0007397);organogenesis (GO:0009887) Cysteine-rich flanking region, N-terminal (IPR000372) high 9.93027284089 201012_at ANXA1 ANX1;ANXA1;LPC1 301 annexin A1 calcium ion binding (GO:0005509);calcium-dependent phospholipid binding (GO:0005544);cell motility (GO:0006928);cell surface receptor linked signal transduction (GO:0007166);inflammatory response (GO:0006954);lipid metabolism (GO:0006629);phospholipase A2 inhibitor activity (GO:0019834);phospholipase inhibitor activity (GO:0004859);phospholipid binding (GO:0005543);receptor binding (GO:0005102) Annexin (IPR001464);Annexin, type I (IPR002388);Annexin, type II (IPR002389);Annexin, type III (IPR002390);Annexin, type IV (IPR002391);Annexin, type V (IPR002392);Annexin, type VI (IPR002393) high 9.89007454061 201497_x_at MYH11 MYH11;SMHC;SMMHC 4629 myosin, heavy polypeptide 11, smooth muscle ATP binding (GO:0005524);actin binding (GO:0003779);calmodulin binding (GO:0005516);cell growth and/or maintenance (GO:0008151);motor activity (GO:0003774);muscle development (GO:0007517);protein amino acid alkylation (GO:0008213);striated muscle contraction (GO:0006941) Bipartite nuclear localization signal (IPR001472);IQ calmodulin-binding region (IPR000048);Myosin N-terminal SH3-like domain (IPR004009);Myosin head (motor domain) (IPR001609);Myosin tail (IPR002928) high 9.88546848538 201842_s_at EFEMP1 DHRD;DRAD;EFEMP1;FBLN3;FBNL;MLVT;S1-5 2202 EGF-containing fibulin-like extracellular matrix protein 1 calcium ion binding (GO:0005509);visual perception (GO:0007601) EGF-like calcium-binding (IPR001881);EGF-like domain (IPR006209) high 9.88392582191 202458_at SPUVE MGC5107;PRSS23-PENDING;SPUVE;ZSIG13 11098 protease, serine, 23 chymotrypsin activity (GO:0004263);hydrolase activity (GO:0016787);proteolysis and peptidolysis (GO:0006508);trypsin activity (GO:0004295) Peptidase S1, chymotrypsin (IPR001254);Peptidase S1A, chymotrypsin (IPR001314);Peptidase, trypsin-like serine and cysteine proteases (IPR009003) high 9.87168323529 216449_x_at Hs.514018 None None CDNA: FLJ22209 fis, clone HRC01496 None None high 9.80499104787 216442_x_at FN1 CIG;FINC;FN1;LETS;MSF 2335 fibronectin 1 acute-phase response (GO:0006953);cell adhesion (GO:0007155);cell migration (GO:0016477);collagen binding (GO:0005518);extracellular matrix structural constituent (GO:0005201);heparin binding (GO:0008201);response to wounding (GO:0009611) Aldehyde dehydrogenase (IPR002086);Bipartite nuclear localization signal (IPR001472);EGF-like domain (IPR006209);Fibronectin, type I (IPR000083);Fibronectin, type III (IPR003961);Fibronectin, type III subdomain (IPR003962);Fibronectin, type III-like fold (IPR008957);Type II fibronectin collagen-binding domain (IPR000562) high 9.76683284119 204345_at COL16A1 447AA;COL16A1 1307 collagen, type XVI, alpha 1 cell adhesion (GO:0007155);collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);phosphate transport (GO:0006817);pregnancy (GO:0007565) Concanavalin A-like lectin/glucanase (IPR008985);Proline-rich region (IPR000694);Thrombospondin, N-terminal (IPR003129) high 9.72602016072 205573_s_at SNX7 DKFZP564F052;MGC8717;SNX7 51375 sorting nexin 7 intracellular protein transport (GO:0006886);intracellular signaling cascade (GO:0007242);protein transporter activity (GO:0008565) Myb DNA-binding domain (IPR001005);Phox-like (IPR001683) high 9.68812652102 202820_at AHR AHR 196 aryl hydrocarbon receptor DNA binding (GO:0003677);apoptosis (GO:0006915);ligand-dependent nuclear receptor activity (GO:0004879);response to stress (GO:0006950);response to xenobiotic stimulus (GO:0009410);signal transduction (GO:0007165);transcription factor activity (GO:0003700);transcription from Pol II promoter (GO:0006366) Basic helix-loop-helix dimerization domain bHLH (IPR001092);PAS (IPR000014) high 9.57253806315 212091_s_at COL6A1 COL6A1;OPLL 1291 collagen, type VI, alpha 1 DNA binding (GO:0003677);cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);collagen (GO:0005202);extracellular matrix structural constituent (GO:0005201);histogenesis and organogenesis (GO:0007397);molecular_function unknown (GO:0005554);phosphate transport (GO:0006817);protein binding (GO:0005515) Proline-rich region (IPR000694);von Willebrand factor, type A (IPR002035) high 9.54593732363 200907_s_at KIAA0992 CGI-151;KIAA0992;SIH002 23022 palladin amino acid metabolism (GO:0006520) Immunoglobulin C-2 type (IPR003598);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);Proline-rich region (IPR000694) high 9.54056272837 221730_at COL5A2 COL5A2 1290 collagen, type V, alpha 2 cell growth and/or maintenance (GO:0008151);collagen (GO:0005202);extracellular matrix glycoprotein (GO:0005207);extracellular matrix structural constituent (GO:0005201);phosphate transport (GO:0006817) Fibrillar collagen, C-terminal (IPR000885);Fibrinogen, beta/gamma chain, C-terminal globular (IPR002181);Proline-rich region (IPR000694);von Willebrand factor, type C (IPR001007) high 9.53039663325 202766_s_at FBN1 FBN;FBN1;MASS;MFS1;OCTD;SGS;WMS 2200 fibrillin 1 (Marfan syndrome) calcium ion binding (GO:0005509);development (GO:0007275);extracellular matrix structural constituent (GO:0005201);skeletal development (GO:0001501);visual perception (GO:0007601) EGF-like calcium-binding (IPR001881);EGF-like domain (IPR006209);EGF-like domain, subtype 2 (IPR000742);Growth factor, receptor (IPR009030);Matrix fibril-associated (IPR002212);Proline-rich region (IPR000694) high 9.51089715344 202336_s_at PAM PAL;PAM;PHM 5066 peptidylglycine alpha-amidating monooxygenase electron transporter activity (GO:0005489);monooxygenase activity (GO:0004497);peptide amidation (GO:0001519);peptidylglycine monooxygenase activity (GO:0004504);protein modification (GO:0006464) Aldehyde dehydrogenase (IPR002086);Copper type II, ascorbate-dependent monooxygenase (IPR000323);PHM/PNGase F Fold (IPR008977);Peptidyl-glycine alpha-amidating monooxygenase (IPR000720) high 9.50406593097 gnf1h07087_at LOC92912 LOC92912 92912 hypothetical protein LOC92912 ligase activity (GO:0016874);ubiquitin conjugating enzyme activity (GO:0004840);ubiquitin cycle (GO:0006512);ubiquitin-protein ligase activity (GO:0004842) Immunoglobulin-like (IPR007110);RWD (IPR006575);Ubiquitin-conjugating enzymes (IPR000608) high 9.46725814314 209156_s_at COL6A2 COL6A2;DKFZp586E1322;PP3610 1292 collagen, type VI, alpha 2 cell-cell adhesion (GO:0016337);collagen (GO:0005202);extracellular matrix organization and biogenesis (GO:0030198);extracellular matrix structural constituent (GO:0005201);muscle development (GO:0007517);phosphate transport (GO:0006817);protein binding, bridging (GO:0030674) Proline-rich region (IPR000694);von Willebrand factor, type A (IPR002035) high 9.44923350408 218135_at PTX1 CDA14;PTX1;cd002 51290 PTX1 protein None None high 9.40856721367 200897_s_at KIAA0992 CGI-151;KIAA0992;SIH002 23022 palladin amino acid metabolism (GO:0006520) Immunoglobulin C-2 type (IPR003598);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);Proline-rich region (IPR000694) high 9.33157963968 204619_s_at CSPG2 CSPG2;VERSICAN 1462 chondroitin sulfate proteoglycan 2 (versican) calcium ion binding (GO:0005509);cell adhesion (GO:0007155);chondroitin sulfate proteoglycan (GO:0005204);development (GO:0007275);glycosaminoglycan binding (GO:0005539);heterophilic cell adhesion (GO:0007157);hyaluronic acid binding (GO:0005540);lectin (GO:0005530);proteoglycan (GO:0005203);sugar binding (GO:0005529) C-type lectin (IPR001304);EGF-like calcium-binding (IPR001881);EGF-like domain (IPR006209);EGF-like domain, subtype 2 (IPR000742);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);Link (IPR000538);Sushi domain/SCR domain/CCP module (IPR000436);Type II EGF-like signature (IPR001438);Type II antifreeze protein (IPR002353) high 9.31895213404 211571_s_at CSPG2 CSPG2;VERSICAN 1462 chondroitin sulfate proteoglycan 2 (versican) calcium ion binding (GO:0005509);cell adhesion (GO:0007155);chondroitin sulfate proteoglycan (GO:0005204);development (GO:0007275);glycosaminoglycan binding (GO:0005539);heterophilic cell adhesion (GO:0007157);hyaluronic acid binding (GO:0005540);lectin (GO:0005530);proteoglycan (GO:0005203);sugar binding (GO:0005529) C-type lectin (IPR001304);EGF-like calcium-binding (IPR001881);EGF-like domain (IPR006209);EGF-like domain, subtype 2 (IPR000742);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);Link (IPR000538);Sushi domain/SCR domain/CCP module (IPR000436);Type II EGF-like signature (IPR001438);Type II antifreeze protein (IPR002353) high 9.30169939523 207714_s_at SERPINH1 CBP1;CBP2;HSP47;RA-A47;SERPINH1;SERPINH2;gp46 871 serine (or cysteine) proteinase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) collagen binding (GO:0005518);heat shock protein activity (GO:0003773);response to stress (GO:0006950);serine-type endopeptidase inhibitor activity (GO:0004867);serpin (GO:0004868) Proteinase inhibititor I4, serpin (IPR000215) high 9.23389058744 209109_s_at TM4SF6 T245;TM4SF6;TSPAN-6 7105 transmembrane 4 superfamily member 6 cell adhesion molecule activity (GO:0005194);cell motility (GO:0006928);positive regulation of I-kappaB kinase/NF-kappaB cascade (GO:0043123);signal transducer activity (GO:0004871) CD9/CD37/CD63 antigen (IPR000301) high 9.20018956498 208789_at PTRF FKSG13;PTRF 284119 polymerase I and transcript release factor None Bipartite nuclear localization signal (IPR001472) high 9.18820784381 gnf1h07549_at LATS2 LATS2 26524 LATS, large tumor suppressor, homolog 2 (Drosophila) ATP binding (GO:0005524);protein amino acid phosphorylation (GO:0006468);protein serine/threonine kinase activity (GO:0004674);transferase activity (GO:0016740);tumor suppressor (GO:0008181) Bipartite nuclear localization signal (IPR001472);Proline-rich region (IPR000694);Protein kinase (IPR000719);Protein kinase C-terminal domain (IPR000961);Serine/threonine protein kinase (IPR002290);Tyrosine protein kinase (IPR001245);UBA-like (IPR009060);Ubiquitin-associated domain (IPR000449) high 9.11926967137 201218_at CTBP2 CTBP2;MGC70870 1488 C-terminal binding protein 2 L-serine biosynthesis (GO:0006564);negative regulation of cell proliferation (GO:0008285);oxidoreductase activity (GO:0016491);oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616);tumor suppressor (GO:0008181);viral replication (GO:0008166) D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain (IPR006140);D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain (IPR006139) high 9.06408357509 202351_at ITGAV CD51;ITGAV;MSK8;VNRA 3685 integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) cell adhesion (GO:0007155);cell adhesion receptor activity (GO:0004895);cell-matrix adhesion (GO:0007160);integrin-mediated signaling pathway (GO:0007229);protein binding (GO:0005515) Bipartite nuclear localization signal (IPR001472);Calcium-binding EF-hand (IPR002048);Integrins alpha chain (IPR000413) high 9.05443685976 201485_s_at RCN2 E6BP;ERC-55;ERC55;RCN2 5955 reticulocalbin 2, EF-hand calcium binding domain calcium ion binding (GO:0005509);protein binding (GO:0005515);tumor suppressor (GO:0008181) Calcium-binding EF-hand (IPR002048) high 8.98441898063 201942_s_at CPD CPD 1362 carboxypeptidase D carboxypeptidase A activity (GO:0004182);carboxypeptidase D activity (GO:0004187);carboxypeptidase activity (GO:0004180);hydrolase activity (GO:0016787);proteolysis and peptidolysis (GO:0006508);zinc ion binding (GO:0008270) Carboxypeptidase regulatory domain (IPR008969);Peptidase M14, carboxypeptidase A (IPR000834);Peptidase M14B (IPR008575) high 8.97574140988 202371_at FLJ21174 FLJ21174 79921 hypothetical protein FLJ21174 None Bipartite nuclear localization signal (IPR001472);Transcription elongation factor A, SII-related (IPR010370) high 8.96406107019 211986_at MGC5395 MGC5395 79026 hypothetical protein MGC5395 intracellular signaling cascade (GO:0007242);neurogenesis (GO:0007399);protein binding (GO:0005515) PDZ/DHR/GLGF domain (IPR001478) high 8.96270157232 203417_at MFAP2 MAGP;MAGP1;MFAP2 4237 microfibrillar-associated protein 2 extracellular matrix glycoprotein (GO:0005207);extracellular matrix structural constituent (GO:0005201) Metridin-like ShK toxin (IPR003582);Microfibril-associated glycoprotein (IPR008673) high 8.94394941033 202551_s_at CRIM1 CRIM1 51232 cysteine-rich motor neuron 1 cysteine-type endopeptidase activity (GO:0004197);insulin-like growth factor binding (GO:0005520);insulin-like growth factor receptor activity (GO:0005010);neurogenesis (GO:0007399);proteolysis and peptidolysis (GO:0006508);regulation of cell growth (GO:0001558);serine-type endopeptidase inhibitor activity (GO:0004867) Insulin-like growth factor-binding protein, IGFBP (IPR000867);Peptidase, eukaryotic cysteine peptidase active site (IPR000169);Proteinase inhibitor I15, antistasin (IPR004094);von Willebrand factor, type C (IPR001007) high 8.92376680213 203180_at ALDH1A3 ALDH1A3;ALDH1A6;ALDH6;RALDH3 220 aldehyde dehydrogenase 1 family, member A3 alcohol metabolism (GO:0006066);aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030);aldehyde dehydrogenase activity (GO:0004028);lipid metabolism (GO:0006629);metabolism (GO:0008152);oxidoreductase activity (GO:0016491) Aldehyde dehydrogenase (IPR002086) high 8.92090420308 221935_s_at MGC34132 MGC34132 285203 hypothetical protein MGC34132 None None low -11.018169328 212998_x_at HLA-DQB1 CELIAC1;HLA-DQB;HLA-DQB1;IDDM1 3119 major histocompatibility complex, class II, DQ beta 1 MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955) Class II histocompatibility antigen, beta chain, beta-1 domain (IPR000353);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006) low -11.1355427255 214084_x_at na None 402545 similar to Neutrophil cytosol factor 1 (NCF-1) (Neutrophil NADPH oxidase factor 1) (47 kDa neutrophil oxidase factor) (p47-phox) (NCF-47K) (47 kDa autosomal chronic granulomatous disease protein) None None low -11.1765180486 209083_at CORO1A CLABP;CLIPINA;CORO1A;Clabp TACO;HAST;HAST3;HCORO1;M-PST;STM;SULT1A3;TACO;TL-PST;p57 11151 coronin, actin binding protein, 1A DNA repair (GO:0006281);actin binding (GO:0003779);amine biosynthesis (GO:0009309);amine metabolism (GO:0009308);aryl sulfotransferase activity (GO:0004062);catecholamine metabolism (GO:0006584);cell motility (GO:0006928);nuclease activity (GO:0004518);phagosome formation (GO:0006912);steroid metabolism (GO:0008202);structural molecule activity (GO:0005198);sulfotransferase activity (GO:0008146);transferase activity (GO:0016740);transport (GO:0006810) Excinuclease ABC, C subunit, N-terminal (IPR000305);Sulfotransferase (IPR000863) low -11.3335050356 208998_at UCP2 SLC25A8;UCP2;UCPH 7351 uncoupling protein 2 (mitochondrial, proton carrier) binding (GO:0005488);mitochondrial transport (GO:0006839);proton transport (GO:0015992);small molecule transport (GO:0006832);transport (GO:0006810);transporter activity (GO:0005215);uncoupling protein activity (GO:0015302) Adenine nucleotide translocator 1 (IPR002113);Mitochondrial brown fat uncoupling protein (IPR002030);Mitochondrial carrier protein (IPR002067);Mitochondrial substrate carrier (IPR001993) low -11.3354347133 204960_at PTPRCAP CD45-AP;LPAP;PTPRCAP 5790 protein tyrosine phosphatase, receptor type, C-associated protein antimicrobial peptide activity (GO:0003795);defense response (GO:0006952) None low -11.4514644953 204961_s_at NCF1 NCF1;NOXO2;p47phox 4687 neutrophil cytosolic factor 1 (47kDa, chronic granulomatous disease, autosomal 1) GTP binding (GO:0005525);GTPase activity (GO:0003924);cellular defense response (GO:0006968);electron transport (GO:0006118);electron transporter activity (GO:0005489);intracellular signaling cascade (GO:0007242);oxygen and reactive oxygen species metabolism (GO:0006800);protein binding (GO:0005515);superoxide metabolism (GO:0006801) Neutrophil cytosol factor 1 (IPR001655);Phox-like (IPR001683);SH3 (IPR001452) low -11.5769744793 209619_at CD74 CD74;DHLAG;HLADG;Ia-GAMMA 972 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) MHC class II receptor activity (GO:0045012);chaperone activity (GO:0003754);class II major histocompatibility complex antigen (GO:0003821);immune response (GO:0006955) MHC class II-associated invariant chain, ectoplasmic trimerization (IPR008933);Thyroglobulin type-1 (IPR000716) low -11.5824246787 212750_at PPP1R16B ANKRD4;KIAA0823;PPP1R16B;TIMAP 26051 protein phosphatase 1, regulatory (inhibitor) subunit 16B protein phosphatase binding (GO:0019903);signal transduction (GO:0007165) Bipartite nuclear localization signal (IPR001472) low -11.6802502257 35974_at LRMP JAW1;LRMP 4033 lymphoid-restricted membrane protein hemocyte development (GO:0007516);vesicle fusion (GO:0006906) MRVI1 (IPR008677) low -11.7957082213 203608_at ALDH5A1 ALDH5A1;SSADH;SSDH 7915 aldehyde dehydrogenase 5 family, member A1 (succinate-semialdehyde dehydrogenase) aminobutyrate catabolism (GO:0009450);aminobutyrate metabolism (GO:0009448);dopamine metabolism (GO:0042417);electron transporter activity (GO:0005489);metabolism (GO:0008152);oxidoreductase activity (GO:0016491);succinate-semialdehyde dehydrogenase activity (GO:0004777) Aldehyde dehydrogenase (IPR002086);Bipartite nuclear localization signal (IPR001472) low -11.9228447619 217022_s_at MGC27165 MGC27165 283650 hypothetical protein MGC27165 None Immunoglobulin C-type (IPR003597);Immunoglobulin V-type (IPR003596);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006) low -12.0376825523 210046_s_at IDH2 ICD-M;IDH;IDH2;IDHM;IDP;mNADP-IDH 3418 isocitrate dehydrogenase 2 (NADP+), mitochondrial carbohydrate metabolism (GO:0005975);glyoxylate cycle (GO:0006097);isocitrate dehydrogenase (NADP+) activity (GO:0004450);main pathways of carbohydrate metabolism (GO:0006092);metabolism (GO:0008152);oxidoreductase activity (GO:0016491);tricarboxylic acid cycle (GO:0006099) Isocitrate dehydrogenase NADP-dependent, eukaryotic (IPR004790);Isocitrate/isopropylmalate dehydrogenase (IPR001804) low -12.1855608692 215379_x_at IGLJ3 IGLJ3;LOC96610 28831 immunoglobulin lambda joining 3 antigen binding (GO:0003823);immune response (GO:0006955) Immunoglobulin C-type (IPR003597);Immunoglobulin V-type (IPR003596);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006) low -12.3587240402 221671_x_at na None 391392 similar to immunoglobulin kappa light chain variable region O11 antigen binding (GO:0003823);immune response (GO:0006955) Immunoglobulin V-type (IPR003596);Immunoglobulin-like (IPR007110) low -12.6525404552 221651_x_at na None 391392 similar to immunoglobulin kappa light chain variable region O11 antigen binding (GO:0003823);immune response (GO:0006955) Immunoglobulin V-type (IPR003596);Immunoglobulin-like (IPR007110) low -13.1386067782 209374_s_at 209374_s_at None None None None Immunoglobulin C-type (IPR003597);Immunoglobulin/major histocompatibility complex (IPR003006) low -13.7131932114 211430_s_at IGHG1 IGHG1 3500 immunoglobulin heavy constant gamma 1 (G1m marker) antigen binding (GO:0003823);immune response (GO:0006955) Immunoglobulin C-type (IPR003597);Immunoglobulin V-type (IPR003596);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006) low -14.0607314935 209138_x_at IGL@ IGL;IGL@ 3535 immunoglobulin lambda locus None None low -14.9709620438 215121_x_at Hs.356861 None None CDNA FLJ26905 fis, clone RCT01427, highly similar to Ig lambda chain C regions None Aminoacyl-tRNA synthetase, class I (IPR001412);Immunoglobulin V-type (IPR003596);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006) low -16.5999180657 214677_x_at IGLJ3 IGLJ3;LOC96610 28831 immunoglobulin lambda joining 3 antigen binding (GO:0003823);immune response (GO:0006955) Immunoglobulin C-type (IPR003597);Immunoglobulin V-type (IPR003596);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)